• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Carmofur

Carmofur

Product ID C0174
Cas No. 61422-45-5
Purity ≥97%
Product Unit SizeCostQuantityStock
250 mg $75.10 In stock
1 g $134.30 In stock
5 g $443.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Carmofur is a pyrimidine analog and derivative of fluorouracil; it exhibits anticancer chemotherapeutic and anti-metastatic activities. Carmofur inhibits thymidylate synthase and acid ceramidase, preventing DNA replication. This compound is clinically used to treat curatively resected colon cancer and breast cancer.

Product Info

Cas No.

61422-45-5

Purity

≥97%

Formula

C11H16FN3O3

Formula Wt.

257.26

Chemical Name

5-Fluoro-N-hexyl-3,4-dihydro-2,4-1(2H)- pyrimidinecarboxamide

IUPAC Name

5-fluoro-N-hexyl-2,4-dioxopyrimidine-1-carboxamide

Synonym

HCFU, Mifurol, Yamaful

Melting Point

110-111°C

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

C0174 MSDS PDF

Info Sheet

C0174 Info Sheet PDF

References

Pizzirani D, Pagliuca C, Realini N, et al. Discovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR). J Med Chem. 2013 May 9;56(9):3518-30. PMID: 23614460.

Sakamoto J, Hamada C, Rahman M, et al. An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer. Jpn J Clin Oncol. 2005 Sep;35(9):536-44. PMID: 16155120.

Morimoto K, Koh M. Postoperative adjuvant use of carmofur for early breast cancer. Osaka City Med J. 2003 Dec;49(2):77-83. PMID: 15179836.

Nakanishi H, Abe A, Inada K, et al. Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil. J Cancer Res Clin Oncol. 1999 Dec;125(12):660-8. PMID: 10592098.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A7203

    AS-703026

    MEK1/2 inhibitor.

    ≥98%
  • S3346

    Silodosin

    α1A-adrenergic antagonist.

    ≥98%
  • I4800

    Imatinib free base

    Inhibitor of Abl, c-Kit, and PDGFR.

    ≥99%
  • F1654

    Fenoldopam Mesylate

    Benzazepine derivative; D1 partial agonist, pot...

    ≥98%
  • D0263

    Dapoxetine Hydrochloride

    SERT inhibitor, potential voltage-gated K+ chan...

    ≥99%
  • R520002

    RN-1747

    TRPV4 agonist

    ≥98%
  • B5753

    Bongkrekic Acid

    Respiratory toxin, mitochondrial permeability t...

    ≥95%
  • K624760

    KPT-276

    CRM1/XPO1 inhibitor.

    ≥99%
  • N3496

    Nizatidine

    Histamine H2 inverse agonist.

    ≥98%
  • Z8401

    Z-VAD-FMK

    Non-specific caspase inhibitor used to prevent ...

    ≥95%
  • E846184

    Everolimus EP Impurity B

    Everolimus impurity

    ≥96% (mix of E/Z)
  • M1745

    Melatonin

    Endogenous hormone involved in circadian rhythm...

    ≥98%
  • A7658

    Atorvastatin Calcium Trihydrate

    Statin; HMG-CoA reductase inhibitor.

    ≥98%
  • B3200

    BI-2536

    PLK1 inhibitor.

    ≥98%
  • V3326

    Virginiamycin S1

    Macrolide antibiotic; peptidyl transferase inhi...

    ≥99%
  • T0140

    TAK-632

    RAF inhibitor.

    ≥99%
  • A7669

    A-type Natriuretic Peptide (1-28), rat

    Endogenous cardiomodulatory peptide; NPR-A agon...

    ≥95%
  • S6134

    Spinorphin, bovine

    Endogenous heptapeptide; P2X3 and N-formylpepti...

    ≥95%
  • A5302

    Anastrozole

    Aromatase inhibitor.

    ≥99%
  • C0021

    Cafestol Acetate

    Diterpene found in brewed, unfiltered coffee; F...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only